sponsored by
simmons hanly conroy
a national law firm
(866) 445-2964
simmons hanly conroy
a national law firm
An advisory panel to the U.S. Food and Drug Administration (FDA) recently voted 20-1 that further assessment of the health risks of testosterone therapy is needed among drugmakers. Among the panel, 16…
read moreThe U.S. Judicial Panel on Multidistrict Litigation has ordered the consolidation of all federal testosterone therapy lawsuits before the Hon. Matthew F. Kennelly in the Northern District of Illinois, U.S. District Court.…
read moreThe U.S. Food and Drug Administration recently submitted a federal proposal to establish stricter safety requirements for transvaginal surgical mesh implants. The devices are often used to repair pelvic collapse in women, and…
read moreMore than 80 percent of prescription drugs in the U.S. are being tested by the Food and Drug Administration (FDA) in its first widespread safety and quality evaluation. The effort will examine…
read moreThree new studies took a deeper look into the U.S. Food and Drug Administration (FDA) regulatory process. Results from the studies found that FDA approval does not necessarily mean the medication or…
read more
Our dedication to customer service, our national resources, and our cumulative centuries of legal experience are what drives our results.
make an appointment
